Company news
ABIONYX Pharma SA news in 2025
ABIONYX Pharma SA's news releases, calls and decks from 2025, newest first.
ABIONYX Pharma Carries Out a Capital Increase With Cancellation of Preferential Subscription Rights in Favor of Certain Categories of Persons, Amounting to Approximately €1.8m
December 17, 2025
ABIONYX Pharma Is Launching a Capital Increase With Cancellation of Preferential Subscription Rights in Favor of Certain Categories of Persons, Amounting to Approximately €1.8m
December 16, 2025
ABIONYX Pharma Reports on Its Business and Cash Position for the Third Quarter of 2025
November 25, 2025
ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis
November 20, 2025
ABIONYX Pharma Enters Advanced Strategic Discussions with IHU SEPSIS, the World’s First Center Dedicated to Sepsis
November 12, 2025
ABIONYX Pharma Announces Advanced Strategic Discussions with IHU SEPSIS, the World's Leading Center Dedicated to Sepsis
November 12, 2025
ABIONYX Pharma Announces Landmark Validation: A Study Published in NATURE Confirms Genetic Causality of Apolipoprotein A-I (ApoA-I) in Sepsis
October 21, 2025
ABIONYX Pharma: 2025 Half-Year Financial Results
September 25, 2025
ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 2nd Quarter 2025
August 28, 2025
ABIONYX Pharma Announces the Start of Discussions With a Major Player in the Field of Sepsis for a Strategic Partnership
August 27, 2025
ABIONYX Pharma Announces Approval of All Resolutions Put to the Vote at Its Combined General Meeting
June 27, 2025
ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 1st Quarter 2025
May 28, 2025